We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+6.55%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$464M
AUM Growth
+$71.8M
Cap. Flow
+$50.4M
Cap. Flow %
10.87%
Top 10 Hldgs %
6.81%
Holding
1,135
New
445
Increased
136
Reduced
132
Closed
422

Sector Composition

Rank Sector Weight
1 Technology 16.86%
2 Healthcare 13.3%
3 Consumer Discretionary 12.71%
4 Financials 12.36%
5 Industrials 12.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOLX
901
DELISTED
Hologic
HOLX
-4,935
Closed -$353K
HOPE icon
902
Hope Bancorp
HOPE
$1.72B
-21,325
Closed -$258K
HPE icon
903
Hewlett Packard
HPE
$63.2B
-59,916
Closed -$1.02M
HTHT icon
904
Huazhu Hotels Group
HTHT
$12.4B
-10,209
Closed -$341K
HUN icon
905
Huntsman Corp
HUN
$2.24B
-36,694
Closed -$922K
HWC icon
906
Hancock Whitney
HWC
$6.13B
-5,517
Closed -$268K
HXL icon
907
Hexcel
HXL
$8.32B
-3,878
Closed -$286K
HZO icon
908
MarineMax
HZO
$800M
-6,629
Closed -$258K
IART icon
909
Integra LifeSciences
IART
$1.54B
-20,472
Closed -$892K
IBKR icon
910
Interactive Brokers
IBKR
$40.9B
-28,184
Closed -$584K
IBN icon
911
ICICI Bank
IBN
$106B
-27,592
Closed -$658K
ICLR icon
912
Icon
ICLR
$12.8B
-1,265
Closed -$358K
IDYA icon
913
IDEAYA Biosciences
IDYA
$3.41B
-6,845
Closed -$244K
IDXX icon
914
Idexx Laboratories
IDXX
$42.9B
-459
Closed -$255K
IMAX icon
915
IMAX
IMAX
$2.38B
-30,097
Closed -$452K
IMVT icon
916
Immunovant
IMVT
$8.09B
-14,534
Closed -$612K
IMXI icon
917
International Money Express
IMXI
$392M
-12,585
Closed -$278K
INFY icon
918
Infosys
INFY
$45B
-31,442
Closed -$578K
ING icon
919
ING
ING
$93.8B
-21,083
Closed -$317K
INN
920
Summit Hotel Properties
INN
$761M
-11,933
Closed -$80.2K
INVH icon
921
Invitation Homes
INVH
$17.7B
-41,909
Closed -$1.43M
IONS icon
922
Ionis Pharmaceuticals
IONS
$9.35B
-9,271
Closed -$469K
IOT icon
923
Samsara
IOT
$19.3B
-20,091
Closed -$671K
IOVA icon
924
Iovance Biotherapeutics
IOVA
$2.23B
-22,712
Closed -$185K
IR icon
925
Ingersoll Rand
IR
$33B
-11,144
Closed -$862K

Similar funds

Fox Run Management's Q1 2024 Portfolio in Review

As of Q1 2024, Fox Run Management held 1,135 positions worth $464M, up 18% from $392M the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Fox Run Management deployed $50.4M of net new capital in Q1 2024, opening 445 new positions and adding to 136 existing holdings. Its largest new stake was iShares US Real Estate ETF: 31,900 shares worth $2.87M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was State Street Financial Select Sector SPDR ETF, an estimated $4.4M trimmed.

  • Fox Run Management's largest Q1 2024 buy was iShares US Real Estate ETF: 31,900 shares worth $2.87M.
  • Fox Run Management added most to Ecolab in Q1 2024, an estimated $1.89M increase.
  • Fox Run Management's biggest Q1 2024 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $4.4M.
  • Fox Run Management fully exited Kimberly-Clark in Q1 2024, selling an estimated $2.33M.
  • Fox Run Management's ten largest holdings make up 6.8% of its $464M portfolio in Q1 2024.
  • Fox Run Management opened 445 new positions and closed 422 in Q1 2024.
  • Fox Run Management's portfolio value rose 18% quarter-over-quarter to $464M.

Based on Fox Run Management's 13F filing for Q1 2024, filed 13 May 2024.